Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.21 | 9e-06 |
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0002 |
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |